JEANNE HOLDREN: Open Payments
NPI 1497860811 · FLORA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 76 payments from 12 companies in 2025. Trend: 2023 $810 · 2024 $1,109 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $222 |
| Otsuka America Pharmaceutical, Inc. | 13 | $220 |
| Teva Pharmaceuticals USA, Inc. | 19 | $217 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| Neurocrine BioSciences, Inc. | 4 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $56 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: CAPLYTA, ARISTADA, REXULTI, AUSTEDO XR, COBENFY, UZEDY, FANAPT, INGREZZA.
Industry payments across IL — which companies pay providers there.
